“Immune Thrombocytopenia (ITP): Does Sequence of Treatment Matter?”

Friday, May 5th, 2017

Walker Auditorium

12:30 p.m. – 1:30 p.m.

Lunch available on a first come, first served basis

Presented by:

William A. Hammond, M.D.

Resident

Mayo Clinic Florida

Learning Objectives:

Upon conclusion of this program, participants should be able to:

• Define immune thrombocytopenia.
• Explain pathophysiologic mechanisms for thrombocytopenia in ITP
• Compare rituximab and splenectomy as treatment options for steroid-resistant ITP

  “Speaker, Doctor William Hammond has noted no financial relationship. He intends to discuss off-label/ investigational use of a commercial product device. Course Director, Doctor James Foran, has no financial relationships to disclose or intentions to discuss off-label/ investigational use of a commercial product device.”

  Mayo Clinic College of Medicine and Science is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

  Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  Please direct all inquiries for non-physician CEU’s to Clinical Education at (3-032

  For further information, contact  Jen Gatchell 3-2795